In support of this, Barbieri et al. (2023) showed that CSCs within MGs exhibit different levels of responsiveness to the CXCL12-CXCR4/CXCR7 chemokine axis, which is known to regulate tumour invasiveness and recurrence. This evidence concerns the gene CXCL12 and neoplasm.